Interferon alfa-2b Interactions
There are 263 drugs known to interact with interferon alfa-2b, along with 11 disease interactions. Of the total drug interactions, 42 are major, 217 are moderate, and 4 are minor.
- View all 263 medications that may interact with interferon alfa-2b
- View interferon alfa-2b disease interactions (11)
Most frequently checked interactions
View interaction reports for interferon alfa-2b and the medicines listed below.
- Activated Charcoal (charcoal)
- Adrenalin (epinephrine)
- Albenza (albendazole)
- Albumarc (albumin human)
- Aloprim (allopurinol)
- Amoxil (amoxicillin)
- Anti-D (RHO) Immunoglobulin (rho (d) immune globulin)
- Avapro (irbesartan)
- Azithromycin Dose Pack (azithromycin)
- Bactrim (sulfamethoxazole / trimethoprim)
- Diltiazem Hydrochloride SR (diltiazem)
- Iodides (sodium iodide)
- Lithium Carbonate ER (lithium)
- Lyrica (pregabalin)
- Metoprolol Tartrate (metoprolol)
- MetroGel (metronidazole topical)
- Mycostatin (nystatin)
- OxyContin (oxycodone)
- Paracetamol (acetaminophen)
- Penicillin G Procaine (procaine penicillin)
- Phenytoin Sodium (phenytoin)
- Retinol (vitamin a topical)
- Tylenol (acetaminophen)
- Valproate Sodium (valproic acid)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Zinc (zinc sulfate)
- Zofran (ondansetron)
Interferon alfa-2b disease interactions
There are 11 disease interactions with interferon alfa-2b which include:
- renal dysfunction
- autoimmune diseases
- hepatic dysfunction
- cardiac disease
- CNS dysfunction
- depression
- thyroid dysfunction
- colitis
- diabetes mellitus
- myelosuppression
- peripheral neuropathy
Report options
More about interferon alfa-2b
- interferon alfa-2b consumer information
- Compare alternatives
- Reviews (9)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antineoplastic interferons
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Epkinly
Epkinly is used for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Nplate
Nplate is used to prevent bleeding episodes in people with chronic immune thrombocytopenic purpura ...
Intron A
Intron A is used for angioblastoma, condylomata acuminata, conjunctival mucosa-associated lymphoid ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Tafinlar
Tafinlar is a prescription medicine used to treat BRAF mutated melanoma, non-small cell lung ...
Mekinist
Mekinist is used to treat melanoma, non-small cell lung cancer, thyroid cancer, solid tumors, and ...
Yervoy
Yervoy (ipilimumab) is a cancer treatment used for lung cancer, melanoma, renal cell carcinoma ...
Ipilimumab
ipilimumab (Yervoy) is an immunotherapy used for melanoma, renal cell carcinoma, non-small cell ...
Dacarbazine
Dacarbazine is used for hodgkin's lymphoma, melanoma, melanoma, metastatic
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.